ENTITY

Argenx SE (ARGX US)

31
Analysis
Health Care • Netherlands
argenx SE operates as a biotechnology company. The Company develops antibody based therapies for the treatment of severe autoimmune diseases and cancer. argenx serves customers in the Netherlands and Belgium.
more
Company Presentation • 17 Aug 2026 20:30

Study update

Company Presentation • 27 Jul 2026 20:00

M&A announcement

Company Presentation • 23 Jul 2026 20:30

Q2 2026

Company Presentation • 24 Jun 2026 02:00

Status update

Company Presentation • 07 May 2026 20:30

Q1 2026

x